Our studio has been called “Nanobot” not without reason. It was our natural time. For many years, we have been…
-
Worldwide, more than 50 million people are affected by neurodegenerative diseases, and Alzheimer’s disease is considered the most frequent type of neurodegenerative disease, occurring in 60% to 80% of all cases. Alzheimer’s pathology results from damage in the central nervous system, including abnormal aggregation of proteins in the nervous system and neurodegenerative processes. Amyloid plaques
-
One year ago, we embarked on a mission to create leading-edge services in the global health sector, aimed at enhancing the quality of life and treating diseases, with the goal of improving human livelihoods. As a team, we wanted to change the world for a better place, and that’s why we declared our vision of
-
May 19, 2023
Recently we have attended two key European events in Biotechnology and Aesthetic medicine – D.B.T in Wiesbaden (Germany) and AMWC in Monaco. We are grateful for all the meaningful discussions and connections during the two events. Here are some insights from German Biotechnology days: The medical industry faces several challenges, and many topics are currently
-
May 17, 2023
Exciting News! Our animation just got featured by Geopop, the largest popular science channel in Italy! Geopop has included parts of our captivating THC animation in their latest video! 🎥✨ It’s an honor to see our work being recognized and shared by such a prestigious platform dedicated to spreading scientific knowledge. We couldn’t be more
-
We are proud to announce that Nanobot Medical has won a Platinum Award at this year’s MUSE Awards for our iBio AI Medical Platform in Oncology animation. Our production team’s tireless efforts have resulted in receiving another prestigious award. This recognition from MUSE Awards is a testament to our team’s unwavering commitment to pushing the